The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

Once activated, neutrophils release neutrophil serine proteases (NSPs), including neutrophil elastase (NE), which are considered central to the pathophysiology of bronchiectasis. Elevated levels ...

Once activated, neutrophils release neutrophil serine proteases (NSPs), including neutrophil elastase (NE), which are considered central to the pathophysiology of bronchiectasis. Elevated levels ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Once activated, neutrophils release neutrophil serine proteases (NSPs), including neutrophil elastase (NE), which are considered central to the pathophysiology of bronchiectasis. Elevated levels of NE ...